← Leaderboards
Rosalyn Wong Sayaman
University Of California, San Francisco
$521,260
Attributed
$521,260
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $174.4K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$521,260 · 1
By mechanism
K01$521,260 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Alan Ashworth$14,084,307
- Nola M. Hylton$19,153,972
- Laura J Van't Veer$11,693,569
- Trever G Bivona$22,714,857
- Mark Jesus Magbanua$1,548,687
Others in their field
Other Rising Stars on “Alternative Treatment”
- Andrew Gardiner · Libero Pharma Limited$6,351,015
- Robert W Cross · University Of Texas Med Br Galveston$4,640,498
- Elie Saade · University Hospitals Of Cleveland$4,095,069
- Simon Vu · Equator Therapeutics, Inc.$3,142,274
- Hsin-Jung Yang · Cedars-Sinai Medical Center$3,123,890
- David T. Kent · Vanderbilt University Medical Center$3,120,041
Research focus
Alternative TreatmentAutoimmuneBedsBiologicalBiological MarkersBiologyBody Mass IndexBrca1 GeneBreastBreast Cancer PatientBreast OncologyCaliforniaCancer BurdenCancer CenterCancer Clinical TrialCancer GenomicsCareer DevelopmentCaringCellsCell TypeChemokineClinical DataClinical TrialsAffect
Grant awards (3)
A systems biology approach to elucidate the biology of immune-associated outcomes in breast cancer$174,420
K01 · FY2025 · CA · contact PI
A systems biology approach to elucidate the biology of immune-associated outcomes in breast cancer$173,620
K01 · FY2024 · CA · contact PI
A systems biology approach to elucidate the biology of immune-associated outcomes in breast cancer$173,220
K01 · FY2023 · CA · contact PI